New cancer clinical trial: Mutation Scores and Differential Protein Evaluating Efficacy in Adjuvant Chemotherapy in HER2(-) Luminal B Breast Cancer

Published on: December 01, 2017 at 10:00AM
Conditions:   Susceptibility, Genetic;   Chemotherapy Effect
Interventions:   Drug: DT group;   Drug: ET group;   Drug: NX group
Sponsor:   Tianjin Medical University Cancer Institute and Hospital
Not yet recruiting
http://ift.tt/2AOvROV